Glipizide Transdermal Pen (1.5mL)
Glipizide is a compounded formulation containing Glipizide, prepared by Mixlab for veterinary use. Available by prescription.
A transdermal pen is a simple way to give your pet medicine through their skin—usually used for cats by applying gel to the inside of their ear.
Step-by-Step:
- Get the pen ready – Twist the pen to dispense a small amount of gel. If it’s your first time, you will need to “prime” it first (the gel should be flush with the edge of the tip)
- Wear gloves – Always use a disposable glove or finger cot so the medication doesn’t absorb into your skin.
- Twist to dose – Follow the pen’s directions (like two full twists) to get the right amount of gel out. Always click in a clockwise direction, clicking counter-clockwise will stop you
- Pick the spot – Apply to a hairless area, usually the inside of your cat’s ear. Make sure the area is clean and dry.
- Apply the gel – Dab the gel directly with the pen or use your gloved finger to rub it in gently. Avoid the ear canal.
- Let it dry – It usually dries in a minute or two. Try to keep your pet from rubbing it off.
- Recap the pen – This keeps the medication fresh.
- Wash your hands – Even if you wore gloves, wash thoroughly after.
- Reward your pet – A treat helps make it a stress-free routine!
- Store properly – Keep at room temp, away from sunlight. Track doses so you know when it’s time to refill.
Important: Only apply where your vet has directed—usually hairless areas. Never apply over fur or broken skin. Keep other pets from licking the area until it’s dry.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Glipizide is a second-generation sulfonylurea utilized in veterinary medicine for the management of blood glucose levels. It is a prescription medication available for use in feline patients, frequently considered by veterinarians for cats presented with type 2 diabetes mellitus when insulin therapy is not prioritized or feasible. Your veterinarian will determine the clinical appropriateness of glipizide based on your cat's health status and diagnostic profile.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, glipizide manages blood sugar by stimulating the release of insulin from functioning pancreatic beta cells. Commonly observed effects include localized digestive changes such as vomiting or a temporary decrease in appetite. Because it manages insulin release, your veterinarian will monitor for observational signs of low blood sugar (hypoglycemia). It is typically used with caution in patients with known severe renal or hepatic impairment. Owners should monitor their cat for any unusual weakness or fainting and contact their veterinarian promptly.
Yes. Glipizide is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab ensures all professional standards are met before dispensing.
Yes. Mixlab specializes in compounding glipizide into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to suit the specific needs of your cat.
Veterinarians discuss glipizide because it signals the pancreas to release more of the body’s natural insulin. This provides a method for managing blood sugar levels in some diabetic cats.
Your veterinarian will recommend regular blood glucose checks and periodic check-ups to monitor pancreatic function. This monitoring ensures the management approach remains safe for your pet.
Unusual weakness or coordination changes can be observational signs of low blood sugar. If you notice these shifts, contact your veterinarian immediately for a clinical review of the management plan.
